ArticleDiscover oncology2026

SMARCA4 mutations drive metastatic progression and predict poor survival in breast cancer based on a real-world cohort study.

Yanfang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.